Jump to ContentJump to Main Navigation
Show Summary Details

European Journal of Nanomedicine

Editor-in-Chief: Hunziker, Patrick / Mollenhauer, Jan

Managing Editor: Löffler, Beat / Salieb-Beugelaar, Georgette

Editorial Board: Alexiou, Christoph / Balogh, Lajos / Barenholz, Yechezkel / Dawson, Kenneth / Fadeel, Bengt / Husseini, Ghaleb / Krol, Silke / Lee, Dong Soo / Lehr, Claus-Michael / Mangge, Harald / Müller, Bert / Peer, Dan / Scoles, Giacinto / Serruys, Patrick / Schwartz, Simo / Szebeni, Janos

CiteScore 2016: 1.06

SCImago Journal Rank (SJR) 2016: 0.411
Source Normalized Impact per Paper (SNIP) 2016: 0.360

See all formats and pricing
More options …


Your Benefits

  • Multidisciplinary approach to human diseases with nanoscience
  • Special attention to niches in the subject matter of EJNM
  • Wide audience – academic and beyond
  • Online publication ahead of print

Aims and Scope

The European Journal of Nanomedicine (EJNM) is a peer-reviewed quarterly journal dedicated to basic and clinical research in Nanomedicine. Its focus lies on the clinical application of nanoscience tools, methods and materials and on the exploration of the implications of Nanomedicine. EJNM covers topics from nano(bio)technological engineering and characterization to clinically translatable innovative prevention, diagnostics, and therapies of major as well as neglected human diseases. It addresses a multidisciplinary readership and provides a comprehensive outlook on the application of nanosciences for the benefit of patients.

  • Experimental, Analytical, (Pre-)Clinical, Preventive and Therapeutic Nanomedicine
  • Medical Nanomaterials
  • Nanobiotechnology
  • Nanodiagnostics
  • Nanotoxicity
  • Nano-Imaging Technologies
  • Vanguard Nano-Technologies
  • Implementation and Implications of Nanomedicine
  • Personalized Nanomedicine

Article formats
  • Original Articles
  • Reviews
  • Short Communications
  • Opinion Papers
  • Letters to the Editor

Supplementary Information


Type of Publication:

scientists in chemistry, physics, engineering, pharmacology, molecular biology, biomedicine, and clinicians, addressing recipients in academic, industrial, and regulatory environments, the informed public and policymakers

Submission of Manuscripts

Instructions for Authors

Dear authors, as of 2018 the European Journal of Nanomedicine will no longer be published by De Gruyter. For inquiries regarding the submission of new manuscripts please contact the European Foundation for Clinical Nanomedicine (CLINAM).

More ...


EJNM was founded in 2008 as the official publishing organ of the CLINAM (European Foundation for Clinical Nanomedicine)

The first issue of Volume 4 in 2012 was the first to be published at De Gruyter

Other publications in the field

Abstracting & Indexing

European Journal of Nanomedicine is covered by the following services:

  • Baidu Scholar
  • Case
  • Celdes
  • Chemical Abstracts Service (CAS) - CAplus
  • Chemical Abstracts Service (CAS) - SciFinder
  • Clarivate Analytics - Emerging Sources Citation Index
  • Clarivate Analytics - Web of Science
  • CNKI Scholar (China National Knowledge Infrastructure)
  • EBSCO (relevant databases)
  • EBSCO Discovery Service
  • Elsevier - Compendex
  • Elsevier - Embase
  • Elsevier - Engineering Village
  • Elsevier - Reaxys
  • Elsevier - SCOPUS
  • Genamics JournalSeek
  • Google Scholar
  • J-Gate
  • JournalGuide
  • JournalTOCs
  • KESLI-NDSL (Korean National Discovery for Science Leaders)
  • Meta (formerly Sciencescape)
  • Microsoft Academic
  • Naviga (Softweco)
  • Paperbase
  • Pirabase
  • Polymer Library
  • Primo Central (ExLibris)
  • ProQuest (relevant databases)
  • Publons
  • ReadCube
  • ResearchGate
  • SCImago (SJR)
  • Sherpa/RoMEO
  • Summon (Serials Solutions/ProQuest)
  • TDNet
  • Ulrich's Periodicals Directory/ulrichsweb
  • WanFang Data
  • WorldCat (OCLC)

Editorial Information

Patrick Hunziker, University Hospital Basel, Switzerland
Jan Mollenhauer, Board of Trustees, European Foundation for Clinical Nanomedicine (CLINAM), Basel, Switzerland

Scientific Managing Editor
Georgette Salieb-Beugelaar, University Hospital Basel, Switzerland

Managing Editor CLINAM
Beat Löffler, European Foundation for Clinical Nanomedicine, Basel, Switzerland

Christoph Alexiou, University Hospital Erlangen, Germany
Yechezkel Barenholz, The Hebrew University of Jerusalem, Israel
Kenneth Dawson, University College Dublin, Ireland
Rutledge Ellis-Behnke, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
Bengt Fadeel, Karolinska Institutet, Stockholm, Sweden
Silke Krol, Neurological Institute Foundation Carlo Besta, Milan, Italy
Dong Soo Lee, Seoul National University, Seoul, South Korea
Claus-Michael Lehr, Saarland University, Saarbrücken, Germany
Eder-Lilia Romero, Quilmes National University, Bernal, Buenos Aires, Argentina
Simó Schwartz, Vall d'Hebron University Hospital, Barcelona, Spain
Janos Szebeni, Semmelweis University, Budapest, Hungary

Editorial Board
Ghaleb Husseini, American University of Sharjah, Sharjah, United Arab Emirates
Harald Mangge, Medical University of Graz, Graz, Austria
Bert Müller, University of Basel, Switzerland
Dan Peer, Tel Aviv University, Tel Aviv, Israel
Giacinto Scoles, Princeton University, Princeton, New Jersey, USA
Patrick W. Serruys, Erasmus University Medical Center, Rotterdam, The Netherlands

Editorial Advisor
Lajos Balogh, AA Nanomedicine & Nanotechnology Consultants, Boston, Massachusetts, USA

Editorial Office - Contact
Alexandra Hinz
De Gruyter
Genthiner Straße 13
10785 Berlin
Tel.: +49 (0)30 260 05 - 358
Fax: +49 (0)30 260 05 - 184
E-Mail: editorial.nanomedicine@degruyter.com
Web: www.degruyter.com/journals/ejnm

Comments (0)

Please log in or register to comment.
Log in